000			03739nam a22003975i 4500
001			86573
003			ES-MaUEC
005			20230207040605.0
007			cr nn 008mamaa
008			151016s2016 ja | s |||| 0|eng d
020			_a9784431556664
040			_aES-MaUEC
050		4	_aRC846 _b2016 EB
082	0	4	_a616.36
245	0	0	_aGene therapy and cell therapy through the liver : _bcurrent aspects and future prospects _cedited by Shuji Terai, Takeshi Suda
250			_a1st ed.
260			_aTokyo _bSpringer _c2016
300			_a1 recurso en línea (X, 185 p.) _b38 ilustraciones, 28 ilustraciones en color
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_a1. Liver-Targeted Gene and Cell Therapies: An Overview -- Part I. Cell Therapy -- 2. Macrophage Therapy for Liver Fibrosis and Regeneration -- 3. Liver Regeneration Therapy Using Autologous Bone Marrow-Derived Cells for Cirrhotic Patients -- 4. Novel Immunotherapy Using Liver Natural Killer Cells for Preventing Recurrence of Hepatocellular Carcinoma in Liver Transplantation -- 5. Cell-Based Immunotherapy for HCC: Our Experiences and Future Directions -- Part II. Gene Therapy -- 6. AAV Vector-Mediated Liver Gene Therapy and Its Implementation for Hemophilia -- 7. Potential Usage of Human Artificial Chromosome for Regenerative Medicine -- 8. Image-Guided Hydrodynamic Gene Delivery to the Liver: Toward Clinical Applications -- Part III. Legal Regulation 9. The Way to Clinical Applications of Human Pluripotent Stem Cells -- 10. Regulation for Gene and Cell Therapy Medicinal Products in Europe -- 11. IPSC-Derived Products: Current Regulations.- 12. Critical Path Initiative for Regenerative Medicine in Japan -- 13. Aseptic Manufacturing of Regenerative Medicine Products Using Isolator Technology -- 14. Cell and Vector Production Facility for Gene Therapy and Cell Therapy
520			_aThis book reports the recent progress in gene and cell therapy through the liver and aims to facilitate a comprehensive understanding of the current aspects and future prospects from basic research to clinical therapies. Edited by pioneering researchers, this volume presents extensive information to principal investigators, researchers, postdocs, and clinicians for examining the wide varieties of pathological conditions both inside and outside the liver. Providing not only the basic and clinical aspects of therapy, this volume is special in that it focuses on the administrative and regulatory difficulties of actual clinical application and legal regulations in different parts of the globe. By indicating the advantages and limitations of the most promising gene and cell therapies targeting the liver, this book will inspire readers to develop a feasible treatment in the next generation
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
650		7	_aHígado _xEnfermedades _9169917 _0comprobar BNE19901084081 _2embne
650		7	_aTerapia genética _0comprobar BNE19960202071 _2embne _9150702
700	1		_aTerai, Shuji _eeditor literario _9100392 _0Local
700	1		_aSuda, Takeshi _eeditor literario _9100393 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-4-431-55666-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9784431556664
907			_a.b12958517 _b10-10-17 _c21-11-16
988			_aSpringer_Medicine_2016
998			_am _a_alco _a_vill _b08-06-17 _cm _dz _eb _feng _gja _h0
945			_aRC846 .G46 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11600093 _z06-04-17
999			_c86573 _d86573 _x1